Yi-Hsiang Chen

Title: Innovations of Yi-Hsiang Chen in Antiviral Treatments

Introduction

Yi-Hsiang Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antiviral treatments. With a total of eight patents to his name, Chen's work focuses on utilizing cyanobacterial biomass for therapeutic purposes.

Latest Patents

One of Yi-Hsiang Chen's latest patents is titled "Use of cyanobacterial biomass in treating hepatitis B virus infection." This patent discloses the use of cyanobacterial biomass for treating chronic hepatitis B virus (HBV) infection. The findings indicate that after at least one month of administration, the cyanobacterial biomass significantly reduces the level of the surface antigen of hepatitis B virus (HBsAg) in the treated subjects. Additionally, it helps mitigate insomnia associated with chronic HBV infection. Another notable patent is the "Antiviral arthrospira maxima extract," which provides various cyanobacterial extracts exhibiting antiviral activity against a wide spectrum of viruses, including enterovirus, respiratory syncytial virus, and Ebola virus. This patent also details the processes for preparing the cyanobacterial extract and its various uses.

Career Highlights

Throughout his career, Yi-Hsiang Chen has worked with notable companies such as Far East Bio-tec Co., Ltd. and Ezconn Corporation. His innovative approaches and research have positioned him as a key figure in the biotechnology sector.

Collaborations

Some of his notable coworkers include Chuang-Chun Chiuh and Shin-Ru Shih, who have collaborated with him on various projects and research initiatives.

Conclusion

Yi-Hsiang Chen's contributions to antiviral treatments through his innovative use of cyanobacterial biomass highlight the potential of biotechnology in addressing viral infections. His work continues to pave the way for new therapeutic options in the medical field.